In 2022, retail volume and value sales of rx/reimbursement adult incontinence remained insignificant in Hong Kong. The Comprehensive Social Security Assistance (CSSA) Scheme is primarily responsible for providing subsidies and reimbursements for adult incontinence products. This scheme offered a safety net for those who are unable to sustain themselves financially, and only older citizens who are enrolled in the CSSA scheme are eligible for reimbursement for adult incontinence products.
The analyst's Rx/Reimbursement adult incontinence in Hong Kong, China report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2027 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
The analyst's Rx/Reimbursement adult incontinence in Hong Kong, China report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2027 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Rx/Reimbursement adult incontinence market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Table of Contents
RX/REIMBURSEMENT ADULT INCONTINENCE IN HONG KONG, CHINA2022 DEVELOPMENTS
- Sales of rx/reimbursement adult incontinence remain insignificant in Hong Kong
- The reimbursement scheme provides little room for category development
EXECUTIVE SUMMARY
- Tissue and hygiene in 2022: The big picture
- 2022 key trends
- Competitive landscape
- Retailing developments
- What next for tissue and hygiene?
- Table 1 Birth Rates 2017-2022
- Table 2 Infant Population 2017-2022
- Table 3 Female Population by Age 2017-2022
- Table 4 Total Population by Age 2017-2022
- Table 5 Households 2017-2022
- Table 6 Forecast Infant Population 2022-2027
- Table 7 Forecast Female Population by Age 2022-2027
- Table 8 Forecast Total Population by Age 2022-2027
- Table 9 Forecast Households 2022-2027
- Table 10 Retail Sales of Tissue and Hygiene by Category: Value 2017-2022
- Table 11 Retail Sales of Tissue and Hygiene by Category: % Value Growth 2017-2022
- Table 12 NBO Company Shares of Retail Tissue and Hygiene: % Value 2018-2022
- Table 13 LBN Brand Shares of Retail Tissue and Hygiene: % Value 2019-2022
- Table 14 Penetration of Private Label in Retail Tissue and Hygiene by Category: % Value 2017-2022
- Table 15 Distribution of Retail Tissue and Hygiene by Format: % Value 2017-2022
- Table 16 Distribution of Retail Tissue and Hygiene by Format and Category: % Value 2022
- Table 17 Forecast Retail Sales of Tissue and Hygiene by Category: Value 2022-2027
- Table 18 Forecast Retail Sales of Tissue and Hygiene by Category: % Value Growth 2022-2027
SOURCES
- Summary 1 Research Sources
